mRNA Expression Patterns of the cGMP-Hydrolyzing Phosphodiesterases Types 2, 5, and 9 during Development of the Rat Brain

Journal of Comparative Neurology

Volumn 467, Issue 4, 2003, Pages 566-580

  Van Staveren, Wilma C G ^a   Steinbusch, Harry W M ^a   Markerink Van Ittersum, Marjanne ^a   Repaske, David R ^b   Goy, Michael F ^c   Kotera, Jun ^d   Omori, Kenji ^d   Beavo, Joseph A ^e   De Vente, Jan ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclic nucleotides; In situ hybridization; PDEs

Indexed keywords

CELL MARKER; CYCLIC GMP; GLIAL FIBRILLARY ACIDIC PROTEIN; HYDROLASE; ISOENZYME; MESSENGER RNA; PHOSPHODIESTERASE;

ADULTHOOD; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN NERVE CELL; BRAIN REGION; BRAIN TISSUE; CELL TYPE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DEVELOPMENTAL STAGE; EMBRYO; GESTATION PERIOD; GLIA CELL; HABENULA; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLFACTORY BULB; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PURKINJE CELL; RNA PROBE;

EID: 0344585989     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.10955     Document Type: Article

References (87)

1. Andreeva SG, Dikkes P, Epstein PM, Rosenberg PA. 2001. Expression of cGMP specific phosphodiesterase 9A mRNA in the rat brain. J Neurosci 21:9068-9076.
2. Baratti CM, Boccia MM. 1999. Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice. Behav Pharmacol 10:731-737.
3. Beavo JA. 1995. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75:725-748.
4. Bernabeu R, Schmitz P, Faillace MP, Izquierdo I, Medina JH. 1996. Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning. Neuroreport 7:585-588.
5. Bernabeu R, Schroder N, Quevedo J, Cammarota M, Izquierdo I, Medina JH. 1997. Further evidence for the involvement of a hippocampal cGMP/cGMP-dependent protein kinase cascade in memory consolidation. Neuroreport 8:2221-2224.
6. Bicker G. 1998. NO news from insect brains. Trends Neurosci 21:349-355.
7. Bicker G. 2001. Sources and targets of nitric oxide signalling in insect nervous systems. Cell Tissue Res 303:137-146.
8. Billingsley ML, Polli JW, Balaban CD, Kincaid RL. 1990. Developmental expression of calmodulin-dependent cyclic nucleotide phosphodiesterase in rat brain. Brain Res Dev Brain Res 53:253-263.
9. Boess FG, Hendrix M, Van Der Staay FJ, Van Staveren W, De Vente J, Sik A, Prickaerts J, Blokland A, Koenig G. 2003. Inhibition of PDE2 - a novel mechanism for the treatment of memory disorders. Book of Abstracts, 6th International Conference AD/PD 2003, May 8-12, 2003, Seville, Spain. p 18.
10. Bredt DS, Snyder SH. 1994. Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory epithelium. Neuron 13:301-313.
11. Broillet MC, Firestein S. 1999. Cyclic nucleotide-gated channels. Molecular mechanisms of activation. Ann NY Acad Sci 868:730-740.
12. Burgunder JM, Cheung PT. 1994. Expression of soluble guanylyl cyclase gene in adult rat brain. Eur J Neurosci 6:211-217.
13. Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP. 2000. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 184:409-420.
14. Chalimoniuk M, Strosznajder JB. 1998. Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide. Mol Chem Neuropathol 35:77-95.
15. Conti M, Jin SL. 1999. The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucleic Acid Res Mol Biol 63:1-38.
16. Davis CW, Kuo JF. 1976. Ontogenetic changes in levels of phosphodiesterase for adenosine 3′:5′-monophosphate and glucosine 3′:5′-monophosphate in the lung, brain and heart from guinea pigs. Biochim Biophys Acta 444:554-562.
17. De Vente J, Hopkins DA, Markerink-van Ittersum M, Emson PC, Schmidt HHH, Steinbusch HWM. 1998. Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-producing structures in the rat brain. Neuroscience 87:207-241.
18. De Vente J, Markerink-van Ittersum M, Van Abeelen J, Emson PC, Axer H, Steinbusch HWM. 2000. NO-mediated cGMP synthesis in cholinergic neurons in the rat forebrain: effects of lesioning dopaminergic or serotonergic pathways on nNOS and cGMP synthesis. Eur J Neurosci 12:507-519.
19. De Vente J, Asan E, Gambaryan S, Markerink-van Ittersum M, Axer H, Gallatz K, Lohmann SM, Palkovits M. 2001. Localization of cGMP-dependent protein kinase type II in rat brain. Neuroscience 108:27-49.
20. Dousa TP. 1999. Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int 55:29-62.
21. Edwards TM, Rickard NS, Ng KT. 2002. Inhibition of guanylate cyclase and protein kinase G impairs retention for the passive avoidance task in the day-old chick. Neurobiol Learn Mem 77:313-326.
22. El-Husseini AE, Williams J, Reiner PB, Pelech S, Vincent SR. 1999. Localization of the cGMP-dependent protein kinases in relation to nitric oxide synthase in the brain. J Chem Neuroanat 17:45-55.
23. Fawcett L, Baxendale R, Stacey P, McGrouther C, Harrow I, Soderling S, Hetman J, Beavo JA, Phillips SC. 2000. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc Natl Acad Sci USA 97:3702-3707.
24. Ferrendelli JA. 1978. Distribution and regulation of cyclic GMP in the central nervous system. Adv Cyclic Nucleotide Res 9:453-464.
25. Fisher DA, Smith JF, Pillar JS, St Denis SH, Cheng JB. 1998. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem 273:15559-15564.
26. Francis SH, Turko IV, Corbin JD. 2001. Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucleic Acid Res Mol Biol 65:1-52.
27. Fujishige K, Kotera J, Omori K. 1999. Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A. Eur J Biochem 266:1118-1127.
28. Furuyama T, Iwahashi Y, Tano Y, Takagi H, Inagaki S. 1994. Localization of 63-kDa calmodulin-stimulated phosphodiesterase mRNA in the rat brain by in situ hybridization histochemistry. Brain Res Mol Brain Res 26:331-336.
29. Garthwaite J. 1991. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14:60-67.
30. Gibbs SM, Truman JW. 1998. Nitric oxide and cyclic GMP regulate retinal patterning in the optic lobe of Drosophila. Neuron 20:83-93.
31. Gibbs SM, Becker A, Hardy RW, Truman JW. 2001. Soluble guanylate cyclase is required during development for visual system function in Drosophila. J Neurosci 21:7705-7714.
32. Gillespie PG, Beavo JA. 1988. Characterization of a bovine cone photoreceptor phosphodiesterase purified by cyclic GMP-sepharose chromatography. J Biol Chem 263:8133-8141.
33. Giordano D, De Stefano ME, Citro G, Modica A, Giorgi M. 2001. Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain. Biochim Biophys Acta 1539:16-27.
34. Giuili G, Luzi A, Poyard M, Guellaen G. 1994. Expression of mouse brain soluble guanylyl cyclase and NO synthase during ontogeny. Brain Res Dev Brain Res 81:269-283.
35. Guipponi M, Scott HS, Kudoh J, Kawasaki K, Shibuya K, Shintani A, Asakawa S, Chen H, Lalioti MD, Rossier C, Minoshima S, Shimizu N, Antonarakis SE. 1998. Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: alternative splicing of mRNA transcripts, genomic structure and sequence. Hum Genet 103:386-392.
36. Hanson KA, Burns F, Rybalkin SD, Wager Miller J, Beavo J, Clarke WR. 1998. Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message. Am J Respir Crit Care Med 158:279-288.
37. Hetman JM, Robas N, Baxendale R, Fidock M, Phillips SC, Soderling SH, Beavo JA. 2000. Cloning and characterization of two splice variants of human phosphodiesterase 11A. Proc Natl Acad Sci USA 97:12891-12895.
38. Houslay MD. 1998. Adaptation in cyclic AMP signalling processes: a central role for cyclic AMP phosphodiesterases. Semin Cell Dev Biol 9:161-167.
39. Iwahashi Y, Furuyama T, Tano Y, Ishimoto I, Shimomura Y, Inagaki S. 1996. Differential distribution of mRNA encoding cAMP-specific phosphodiesterase isoforms in the rat brain. Brain Res Mol Brain Res 38:14-24.
40. Izquierdo LA, Vianna M, Barros DM, Mello e Souza T, Ardenghi P, Sant'Anna MK, Rodrigues C, Medinam JH, Izquierdo I. 2000. Short- and long-term memory are differentially affected by metabolic inhibitors given into hippocampus and entorhinal cortex. Neurobiol Learn Mem 73:141-149.
41. Juilfs DM, Fulle HJ, Zhao AZ, Houslay MD, Garbers DL, Beavo JA. 1997. A subset of olfactory neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a unique olfactory signal transduction pathway. Proc Natl Acad Sci USA 94:3388-3395.
42. Juilfs DM, Soderling S, Burns F, Beavo JA. 1999. Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs). Rev Physiol Biochem Pharmacol 135:67-104.
43. Kendrick KM, Guevara-Guzman R, Zorrilla J, Hinton MR, Broad KD, Mimmack M, Ohkura S. 1997. Formation of olfactory memories mediated by nitric oxide. Nature 388:670-674.
44. Kincaid RL, Balaban CD, Billingsley ML. 1987. Differential localization of calmodulin-dependent enzymes in rat brain: evidence for selective expression of cyclic nucleotide phosphodiesterase in specific neurons. Proc Natl Acad Sci USA 84:1118-1122.
45. Kind PC, Neumann PE. 2001. Plasticity: downstream of glutamate. Trends Neurosci 24:553-555.
46. Kingston PA, Zufall F, Barnstable CJ. 1999. Widespread expression of olfactory cyclic nucleotide-gated channel genes in rat brain: implications for neuronal signalling. Synapse 32:1-12.
47. Kotera J, Yanaka N, Fujishige K, Imai Y, Akatsuka H, Ishizuka T, Kawashima K, Omori K. 1997. Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development. Eur J Biochem 249:434-442.
48. Kotera J, Fujishige K, Akatsuka H, Imai Y, Yanaka N, Omori K. 1998. Novel alternative splice variants of cGMP-binding cGMP-specific phosphodiesterase. J Biol Chem 273:26982-26990.
49. Kotera J, Fujishige K, Imai Y, Kawai E, Michibata H, Akatsuka H, Yanaka N, Omori K. 1999a. Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterases. Eur J Biochem 262:866-873.
50. Kotera J, Fujishige K, Yuasa K, Omori K. 1999b. Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP. Biochem Biophys Res Commun 261:551-557.
51. Kotera J, Fujishige K, Omori K. 2000. Immunohistochemical localization of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in rat tissues. J Histochem Cytochem 48:685-693.
52. Loughney K, Hill TR, Florio VA, Uher L, Rosman GJ, Wolda SL, Jones BA, Howard ML, McAllister-Lucas LM, Sonnenburg WK, Francis SH, Corbin JD, Beavo JA, Ferguson K. 1998. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase. Gene 216:139-147.
53. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA. 2000. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52:375-414.
54. Markerink-Van Ittersum M, Steinbusch HWM, De Vente J. 1997. Region-specific developmental patterns of atrial natriuretic factor- and nitric oxide-activated guanylyl cyclases in the postnatal frontal rat brain. Neuroscience 78:571-587.
55. McPhee I, Cochran S, Houslay MD. 2001. The novel long PDE4A10 cyclic AMP phosphodiesterase shows a pattern of expression within brain that is distinct from the long PDE4A5 and short PDE4A1 isoforms. Cell Signal 13:911-918.
56. Miro X, Perez-Torres S, Palacios JM, Puigdomenech P, Mengod G. 2001. Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs. Synapse 40:201-214.
57. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. New York: Academic Press.
58. Paxinos G, Ashwell KWS, Törk I. 1994. Atlas of the developing rat nervous system. New York: Academic Press.
59. Polleux F, Morrow T, Ghosh A. 2000. Semaphorin 3A is a chemoattractant for cortical apical dendrites. Nature 404:567-573.
60. Prickaerts J, Steinbusch HWM, Smits JF, De Vente J. 1997. Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: effects of 7-nitroindazole and zaprinast. Eur J Pharmacol 337:125-136.
61. Prickaerts J, de Vente J, Honig W, Steinbusch HWM, Blokland A. 2002a. cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation. Eur J Pharmacol 436:83-87.
62. Prickaerts J, Van Staveren WCG, Sik A, Markerink-van Ittersum M, Niewöhner U, Van der Staay FJ, Blokland A, De Vente J. 2002b. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience 113:351-361.
63. Reinhardt RR, Bondy CA. 1996. Differential cellular pattern of gene expression for two distinct cGMP-inhibited cyclic nucleotide phosphodiesterases in developing and mature rat brain. Neuroscience 72:567-578.
64. Repaske DR, Corbin JG, Conti M, Goy MF. 1993. A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain. Neuroscience 56:673-686.
65. Rosman GJ, Martins TJ, Sonnenburg WK, Beavo JA, Ferguson K, Loughney K. 1997. Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3′,5′-cyclic nucleotide phosphodiesterase. Gene 191:89-95.
66. Schachtner J, Homberg U, Truman JW. 1999. Regulation of cyclic GMP elevation in the developing antennal lobe of the Sphinx moth, Manduca sexta. J Neurobiol 41:359-375.
67. Schmidt HH, Gagne GD, Nakane M, Pollock JS, Miller MF, Murad F. 1992. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem 40:1439-1456.
68. Scholz NL, Truman JW. 2000. Invertebrate models for studying NO-mediated signaling. In: Steinbusch HWM, De Vente J, Vincent SR, editors. Functional neuroanatomy of the nitric oxide system. Amsterdam: Elsevier. p 417-441.
69. Scholz NL, De Vente J, Truman JW, Graubard K. 2001. Neural network partitioning by NO and cGMP. J Neurosci 21:1610-1618.
70. Simpson PJ, Miller I, Moon C, Hanlon AL, Liebl DJ, Ronnett GV. 2002. Atrial natriuretic peptide type C induces a cell-cycle switch from proliferation to differentiation in brain-derived neurotrophic factor- or nerve growth factor-primed olfactory receptor neurons. J Neurosci 22:5536-5551.
71. Smoake JA, Song SY, Cheung WY. 1974. Cyclic 3′,5′-nucleotide phosphodiesterase. Distribution and developmental changes of the enzyme and its protein activator in mammalian tissues and cells. Biochim Biophys Acta 341:402-411.
72. Soderling SH, Beavo JA. 2000. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol 12:174-179.
73. Soderling SH, Bayuga SJ, Beavo JA. 1998. Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases. J Biol Chem 273:15553-15558.
74. Soderling SH, Bayuga SJ, Beavo JA. 1999. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Proc Natl Acad Sci USA 96:7071-7076.
75. Song HJ, Poo MM. 1999. Signal transduction underlying growth cone guidance by diffusible factors. Curr Opin Neurobiol 9:355-363.
76. Song H, Ming G, He Z, Lehmann M, McKerracher L, Tessier-Lavigne M, Poo M. 1998. Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science 281:1515-1518.
77. Sonnenburg WK, Mullaney PJ, Beavo JA. 1991. Molecular cloning of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase cDNA. Identification and distribution of isozyme variants. J Biol Chem 266:17655-17661.
78. Steinbusch HWM, Allen GV, De Vente J, Hopkins DA. 2001. The interaction between the histaminergic system and the NO-cGMP pathway: a functional neuroanatomical study in the mammillary region and cerebral cortex of the rat. In: Watanabe T, Timmerman H, Yanai K, editors. Histaminergic research in the new millenium. Amsterdam: Elsevier. p 51-59.
79. Thomas MK, Francis SH, Corbin JD. 1990. Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. J Biol Chem 265:14964-14970.
80. Truman JW, De Vente J, Ball EE. 1996. Nitric oxide-sensitive guanylate cyclase activity is associated with the maturational phase of neuronal development in insects. Development 122:3949-3958.
81. Van Staveren WCG, Markerink-van Ittersum M, Steinbusch HWM, De Vente J. 2001. The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat. Brain Res 888:275-286.
82. Van Wagenen S, Rehder V. 1999. Regulation of neuronal growth cone filopodia by nitric oxide. J Neurobiol 39:168-185.
83. Watts VJ. 2002. Molecular mechanisms for heterologous sensitization of adenylate cyclase. J Pharmacol Exp Ther 302:1-7.
84. Wedel BJ, Garbers DL. 2001. The guanylyl cyclase family at Y2K. Annu Rev Physiol 63:215-233.
85. Wei JY, Roy DS, Leconte L, Barnstable CJ. 1998. Molecular and pharmacological analysis of cyclic nucleotide-gated channel function in the central nervous system. Prog Neurobiol 56:37-64.
86. Yan C, Bentley JK, Sonnenburg WK, Beavo JA. 1994. Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterases in the mouse brain. J Neurosci 14:973-984.
87. Yang Q, Paskind M, Bolger G, Thompson WJ, Repaske DR, Cutler LS, Epstein PM. 1994. A novel cyclic GMP stimulated phosphodiesterase from rat brain. Biochem Biophys Res Commun 205:1850-1858.